NI
53
3
AAPL
65
4
AVB
69
4
GS
79
3
GOOG
89
2
EXPE
61
5
CCI
36
3
MMM
30
-5
NAVI
32
-9
BDX
54
7
ZION
55
3
PCG
93
4
PBI
49
10
CHRW
64
16
MOS
19
-6
SYF
95
3
GE
70
3
CI
52
-14
TROW
56
2
BAX
41
-4
NI
53
3
AAPL
65
4
AVB
69
4
GS
79
3
GOOG
89
2
EXPE
61
5
CCI
36
3
MMM
30
-5
NAVI
32
-9
BDX
54
7
ZION
55
3
PCG
93
4
PBI
49
10
CHRW
64
16
MOS
19
-6
SYF
95
3
GE
70
3
CI
52
-14
TROW
56
2
BAX
41
-4
Financhill
Back

Sarepta Therapeutics Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
53

SRPT
Sarepta Therapeutics

Last Price:
130.46
Seasonality Move:
16.32%
Sell
33

APLS
Apellis Pharmaceuticals

Last Price:
47.47
Seasonality Move:
-1.82%
Buy
53
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.58. The Score for SRPT is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
33
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $47.49. The Score for APLS is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.58
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $47.49
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.1 Buy
Relative Strength Index (14 RSI): 62.61 Buy
Chaikin Money Flow: -1849311 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (119.44 - 129.14) Buy
Bollinger Bands (100): (105.04 - 131.84) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.84 Sell
Relative Strength Index (14 RSI): 40.51 Sell
Chaikin Money Flow: 695052 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (47.36 - 56.02) Sell
Bollinger Bands (100): (53.3 - 66.72) Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 126.77 Buy
20-day SMA: 123.47 Buy
50-day SMA: 125.78 Buy
200-day SMA: 112.03 Buy
8-day EMA: 127.12 Buy
20-day EMA: 125.01 Buy
50-day EMA: 123.64 Buy
200-day EMA: 116.53 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.75 Sell
20-day SMA: 50.26 Sell
50-day SMA: 56.3 Sell
200-day SMA: 51.07 Sell
8-day EMA: 47.54 Sell
20-day EMA: 50.03 Sell
50-day EMA: 54.45 Sell
200-day EMA: 57.01 Sell

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.50 per share, an increase next quarter of $3.89 per share, an increase this year of $6.87 per share, and an increase next year of $5.50 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.84 per share, an increase next quarter of $0.56 per share, an increase this year of $3.56 per share, and an increase next year of $1.93 per share.

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):